Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Polixenia Iorga"'
Autor:
Andreea Ruxandra ALBU, Delia Maria GRADINARU, Adrian DUMITRU, Maria SAJIN, Polixenia IORGA, Monica Mihaela CIRSTOIU
Publikováno v:
Modern Medicine, Vol 29, Iss 3, Pp 247-252 (2022)
Metaplastic breast cancer (MBC) is a rare, aggressive form of breast cancer first described by pathologists in 2000. It is usually discovered in advanced stages and has a low survival rate. It is divided into various subtypes: low- grade adenosquamou
Externí odkaz:
https://doaj.org/article/1b55c54fc3df456a92b3011220a77b30
Autor:
Eirini Papadopoulou, Nikolaos Tsoulos, Vasiliki Metaxa-Mariatou, Aikaterini Tsantikidi, Georgios Kapetsis, Chrysiida Florou-Chatzigiannidou, Sonia Maravelaki, Evgenia Bourkoula, Dimitrios Fotiou, Georgios Tsaousis, Nikolaos Touroutoglou, Dimitrios Trafalis, Ioannis Boukovinas, Ioannis Varthalitis, Zacharenia Saridaki, Charalampos Zoublios, Eleni Galani, George Papatsibas, Christos Papadimitriou, Tania Zlatintsi, Polixenia Iorga, Bülent Orhan, Sualp Tansan, Tahsin Özatlı, George Nasioulas
Publikováno v:
Cancer Research. 82:P5-13
Background: Comprehensive tumor analysis by Next Generation Sequencing (NGS) is imperative for targeted and immunotherapy related biomarkers’ analysis in metastatic breast cancer enabling personalization of cancer treatment in these patients. In pa
Autor:
Mircea Dediu, Alexandru A, Teodor Horvat, Rodica Anghel, Constantin Grozavu, Alin Tarlea, Ioan Cordos, Cornel Savu, Polixenia Iorga, Claudiu Nistor, Geanina Miron
Publikováno v:
Lung Cancer. 47:93-101
Summary Background: The impact of adjuvant chemotherapy (CT) in the management of resectable non-small cell lung cancer (NSCLC) is highly debated. The aim of the study was to evaluate the outcome of this category of patients, treated at the Military
Autor:
Mircea, Dediu, Teodor, Horvat, Alin, Tarlea, Rodica, Anghel, Ioan, Cordos, Geanina, Miron, Polixenia, Iorga, Aurelia, Alexandru, Claudiu, Nistor, Constantin, Grozavu, Cornel, Savu
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 47(1)
The impact of adjuvant chemotherapy (CT) in the management of resectable non-small cell lung cancer (NSCLC) is highly debated. The aim of the study was to evaluate the outcome of this category of patients, treated at the Military Hospital Bucharest (